OBJECTIVES: This paper documents individual asthma action plan presence and quick relief medication (albuterol) availability for elementary students enrolled in five Alabama school systems. PATIENTS AND METHODS: Data were obtained during baseline data collection (fall 2005) of a school-based supervised asthma medication trial. All students attended 1 of 36 participating elementary schools across five school systems in Jefferson County, Alabama. In addition, they had to have physician-diagnosed asthma requiring daily controller medication. Each school system had its own superintendent and elected school board. Asthma action plan presence and albuterol availability was confirmed by study personnel. Asthma action plans had to contain daily and acute asthma management instructions. Predictors of asthma action plan presence and albuterol availability were also investigated. Associations between albuterol availability and self-reported characteristics including health care utilization prior to study enrollment and outcomes during the study baseline period were also investigated. RESULTS: Enrolled students had a mean (SD) age of 11.0 (2.1) years, 91% were African American, and 79% had moderate persistent asthma. No student had a complete asthma action plan on file and only 14% had albuterol physically available at school. Albuterol availability was not predicted by gender, race, insurance status, second-hand smoke exposure, need for pre-exercise albuterol, asthma severity, or self-reported health care utilization prior to study enrollment. Albuterol availability did not predict school absences, red/yellow peak flow recordings, or medication adherence during the study's baseline period. CONCLUSION: Despite policies permitting students to possess albuterol, few elementary students across five independent school systems in Alabama actually had it readily available at school.
OBJECTIVES: This paper documents individual asthma action plan presence and quick relief medication (albuterol) availability for elementary students enrolled in five Alabama school systems. PATIENTS AND METHODS: Data were obtained during baseline data collection (fall 2005) of a school-based supervised asthma medication trial. All students attended 1 of 36 participating elementary schools across five school systems in Jefferson County, Alabama. In addition, they had to have physician-diagnosed asthma requiring daily controller medication. Each school system had its own superintendent and elected school board. Asthma action plan presence and albuterol availability was confirmed by study personnel. Asthma action plans had to contain daily and acute asthma management instructions. Predictors of asthma action plan presence and albuterol availability were also investigated. Associations between albuterol availability and self-reported characteristics including health care utilization prior to study enrollment and outcomes during the study baseline period were also investigated. RESULTS: Enrolled students had a mean (SD) age of 11.0 (2.1) years, 91% were African American, and 79% had moderate persistent asthma. No student had a complete asthma action plan on file and only 14% had albuterol physically available at school. Albuterol availability was not predicted by gender, race, insurance status, second-hand smoke exposure, need for pre-exercise albuterol, asthma severity, or self-reported health care utilization prior to study enrollment. Albuterol availability did not predict school absences, red/yellow peak flow recordings, or medication adherence during the study's baseline period. CONCLUSION: Despite policies permitting students to possess albuterol, few elementary students across five independent school systems in Alabama actually had it readily available at school.
Authors: Lynn B Gerald; Roni Grad; Anne Turner-Henson; Coralie Hains; Shenghui Tang; Ronald Feinstein; Keith Wille; Sue Erwin; William C Bailey Journal: Pediatrics Date: 2004-10 Impact factor: 7.124
Authors: Karen McCoy; David M Shade; Charles G Irvin; John G Mastronarde; Nicola A Hanania; Mario Castro; N R Anthonisen Journal: J Allergy Clin Immunol Date: 2006-10-23 Impact factor: 10.793
Authors: Lynn B Gerald; Leslie A McClure; Joan M Mangan; Kathy F Harrington; Linda Gibson; Sue Erwin; Jody Atchison; Roni Grad Journal: Pediatrics Date: 2009-02 Impact factor: 7.124
Authors: Lynn B Gerald; Leslie Ain McClure; Kathy F Harrington; Joan M Mangan; Linda Gibson; Jody Atchison; Roni Grad Journal: Contemp Clin Trials Date: 2007-08-07 Impact factor: 2.226
Authors: Anna Volerman; Ashley A Lowe; Andrea A Pappalardo; Charmayne M C Anderson; Kathryn V Blake; Tyra Bryant-Stephens; Thomas Carr; Heather Carter; Lisa Cicutto; Joe K Gerald; Tina Miller; Nuala S Moore; Hanna Phan; S Christy Sadreameli; Andrea Tanner; Tonya A Winders; Lynn B Gerald Journal: Am J Respir Crit Care Med Date: 2021-09-01 Impact factor: 21.405
Authors: Victoria Rivkina; David E Tapke; Lilliana D Cardenas; Blair Harvey-Gintoft; Stephanie A Whyte; Ruchi S Gupta Journal: BMC Public Health Date: 2014-12-06 Impact factor: 3.295